Login/Sign Up
₹193.1*
MRP ₹214.5
10% off
₹182.32*
MRP ₹214.5
15% CB
₹32.18 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Online payment accepted
Whats That
About Pepar 2.25G Injection
Pepar 2.25G Injection belongs to the 'Antibiotics' class of drugs, primarily used to treat bacterial infections. It is used to treat various hospital-acquired and ventilator-associated pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections (like diabetic foot infections) and uterine infections. Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly.
Pepar 2.25G Injection contains two medicines, namely: Piperacillin (Penicillin antibiotic) and Tazobactam (beta-lactamase inhibitor). Piperacillin belongs to the class of 'Penicillin antibiotics.' It has bactericidal (ability to kill bacteria) activity against gram-positive and gram-negative aerobic (requires oxygen to survive) and anaerobic (survives with little or no oxygen) bacteria. Piperacillin acts by binding to the penicillin-binding proteins (PBPs) inside the bacterial cell wall and inhibits its cell wall synthesis. Tazobactam is a beta-lactamase inhibitor. Beta-lactamases are the enzymes produced by bacteria to gain multi-resistance to β-lactam antibiotics, such as penicillins and cephalosporins. Tazobactam prevents the breakdown of other antibiotics by beta-lactamase enzyme-producing organisms. In Pepar 2.25G Injection, Tazobactam works by preventing bacteria from destroying Piperacillin.
Pepar 2.25G Injection will be administered by a healthcare professional. Like all medicines, Pepar 2.25G Injection also causes side effects, although not everybody gets them. Common side effects of Pepar 2.25G Injection include nausea, constipation, diarrhoea, headache, and trouble sleeping. If any of these effects persist or worsen, seek medical advice promptly.
Brief your medical history to the doctor if you have any allergic reactions to antibiotics. Please inform your doctor if you have any liver, kidney diseases, bleeding disorders, and fits before using Pepar 2.25G Injection. Do not use Pepar 2.25G Injection while having vaccinations with live bacterial vaccines (typhoid vaccine) since Pepar 2.25G Injection may affect vaccines' activity. Pepar 2.25G Injection should be used during pregnancy only if the doctor advises you. It is also excreted into breast milk in small amounts. Hence, it is recommended to consult your doctor if you are pregnant or breastfeeding before taking Pepar 2.25G Injection.
Uses of Pepar 2.25G Injection
Directions for Use
Medicinal Benefits
Pepar 2.25G Injection contains two medicines, namely: Piperacillin and Tazobactam. Piperacillin is a Penicillin antibiotic. It acts by binding to the penicillin-binding proteins (PBPs) inside the bacterial cell wall and inhibits its cell wall synthesis. Tazobactam is a beta-lactamase inhibitor that prevents the breakdown of other antibiotics by beta-lactamase enzyme-producing organisms. In Pepar 2.25G Injection, Tazobactam works by preventing bacteria from destroying Piperacillin. Thus, Pepar 2.25G Injection helps treat various bacterial infections of the stomach, lungs, skin and uterus.
Storage
Side Effects of Pepar 2.25G Injection
Drug Warnings
If you have a history of any cystic fibrosis (damaged lungs and digestive system), kidney disease, fits, colitis (inflammation of the colon), bleeding disorders, or heart or liver diseases, please inform your doctor before starting Pepar 2.25G Injection. Please seek medical advice if you are pregnant or breastfeeding before taking Pepar 2.25G Injection. Patients aged above 65 years are not at an increased risk of having side effects. However, the dosage should be adjusted if the patient has a history of renal impairment. Safety and efficacy of Pepar 2.25G Injection in children less than two months of age have not been established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
by Others
by Others
by Others
by Others
by Others
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Drug-Diseases Interactions
Login/Sign Up
Pepar 2.25G Injection contains Piperacillin and Tazobactam. Piperacillin inhibits bacterial cell wall synthesis, and Tazobactam prevents the bacteria from gaining resistance against Piperacillin. Thus Pepar 2.25G Injection helps in treating various bacterial infections.
Pepar 2.25G Injection should be used with proper caution and doctor consultation if you have any cystic fibrosis (damaged lungs and digestive system), kidney disease, fits, colitis (inflammation of the colon), bleeding disorders, heart or liver diseases and undergoing dialysis.
Pepar 2.25G Injection can affect live vaccines like typhoid vaccine and decrease their effectiveness. Please consult a doctor before you start Pepar 2.25G Injection if you are undergoing any vaccinations.
It is recommended to complete the course of Pepar 2.25G Injection even if you feel better as it is an antibiotic, and stopping it midway may lead to recurring infections. Continue taking Pepar 2.25G Injection for as long as your doctor has prescribed to treat your condition effectually.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly. Bacteria occur in three basic shapes: spherical, rod and spiral-shaped. Bacteria may be gram-positive (have thick cell wall) or gram-negative (do not have a cell wall). Some common symptoms of a bacterial infection include cough, fever and tiredness.
Hospital-acquired pneumonia/ nosocomial pneumonia: It is a lower respiratory infection of the lungs that occurs during a hospital stay.
Ventilator-associated pneumonia: A lung infection occurs in people who are on mechanical ventilation breathing machines in hospitals.